IMMUNIC, INC. — Director's Dealing 2025

Jun 9, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2025-06-05

Reporting Person: Rudick Richard Alan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-05	Stock Option	$0.7729	A	150000	Acquired	2035-06-05	Common Stock (150000)	Direct

Footnotes

F1: The option vests in monthly increments over a period of one year from the grant date.